Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients - PubMed (original) (raw)
Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients
Christian Woiciechowsky et al. J Trauma. 2002 Feb.
Abstract
Background: Brain injury as well as early inflammatory and endocrine responses were found to be indicators for infectious complications in patients with multiple injuries. In this context, brain-derived inflammatory response as well as centrally triggered neuroendocrine activation and systemic immunodepression seem to be of major importance. Therefore, we hypothesize that a circulating index of inflammatory or endocrine function measured soon after brain injury (in patients with admission Glasgow Coma Scale [GCS] score of 4-7) would discriminate severe from moderate injury as indexed by GCS status on postinjury day 7.
Methods: In a retrospective study, 25 patients with either acute traumatic brain injury or cerebral hemorrhage and an initial GCS score of 4 to 7 were examined. Blood samples were obtained at different time points, and different immune variables and neuroendocrine hormones were determined. According to the GCS score on day 7, patients were divided into two groups (GCS score > or = 8, moderate brain injury; and GCS score < 8, severe brain injury or patients who died within the first week) for comparison of variables. Concluding from the results of this retrospective analysis, in a prospective study patients (n = 26) were divided into two groups according to their interleukin (IL)-6 plasma concentrations on day 1 (IL-6 > or = 100 pg/mL and IL 6 < 100 pg/mL). After 7 days, the GCS score, the infection rate, and the mortality were compared between these two groups.
Results: In the retrospective study, we could show that severe brain injury (as assessed by GCS score and mortality on day 7) was associated with high plasma levels of pro- and anti-inflammatory cytokines, acute phase proteins, and neuroendocrine hormones within 2 to 6 hours after the acute event. Among the investigated variables, elevated IL-6 plasma concentrations were stable up to 1 day after the acute event with a high predictive value with regard to the short-term prognosis and incidence of infectious complications within the first week. Because of this stability during the first 24 hours, we selected IL-6 for further studies. In the prospective study with a calculated cut-off IL-6 plasma concentration of 100 pg/mL on day 1, the predictive value of this parameter regarding the severity of the brain injury was fully confirmed (positive predictive value, 0.94; this value represents the observed pretest probability of 0.62). All patients who died (n = 5) or developed infectious complications within the first week (n = 8) showed plasma IL-6 levels > or = 100 pg/mL on day 1.
Conclusion: The IL-6 plasma level 1 day after the acute event with a cut-off of 100 pg/mL (Immulite) seems to be a predictor for short-term prognosis and infectious complications in brain-injured patients.
Similar articles
- Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury.
Hergenroeder GW, Moore AN, McCoy JP Jr, Samsel L, Ward NH 3rd, Clifton GL, Dash PK. Hergenroeder GW, et al. J Neuroinflammation. 2010 Mar 11;7:19. doi: 10.1186/1742-2094-7-19. J Neuroinflammation. 2010. PMID: 20222971 Free PMC article. - [Dynamic changes of serum interleukin-6 and interleukin-8 in patients with acute traumatic brain injury and the clinical significance].
He LM, Qiu BH, Qi ST, Fang LX, Liu XJ. He LM, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2009 May;29(5):999-1001. Nan Fang Yi Ke Da Xue Xue Bao. 2009. PMID: 19460731 Chinese. - Analysis of the inflammatory storm response and heparin binding protein levels for the diagnosis and prognosis of sepsis-associated encephalopathy.
Yu D, Liu J, Song X, Ao Y, Li X, Han Y. Yu D, et al. Eur J Med Res. 2025 Feb 18;30(1):116. doi: 10.1186/s40001-025-02369-x. Eur J Med Res. 2025. PMID: 39966958 Free PMC article. - Protein S-100B--a prognostic marker for cerebral damage.
Stroick M, Fatar M, Ragoschke-Schumm A, Fassbender K, Bertsch T, Hennerici MG. Stroick M, et al. Curr Med Chem. 2006;13(25):3053-60. doi: 10.2174/092986706778521751. Curr Med Chem. 2006. PMID: 17073646 Review. - Cerebral endothelial damage after severe head injury.
Yokota H. Yokota H. J Nippon Med Sch. 2007 Oct;74(5):332-7. doi: 10.1272/jnms.74.332. J Nippon Med Sch. 2007. PMID: 17965526 Review.
Cited by
- Clinical evidence of inflammation driving secondary brain injury: a systematic review.
Hinson HE, Rowell S, Schreiber M. Hinson HE, et al. J Trauma Acute Care Surg. 2015 Jan;78(1):184-91. doi: 10.1097/TA.0000000000000468. J Trauma Acute Care Surg. 2015. PMID: 25539220 Free PMC article. Review. - Impact of Age on Plasma Inflammatory Biomarkers in the 6 Months Following Mild Traumatic Brain Injury.
Thompson HJ, Martha SR, Wang J, Becker KJ. Thompson HJ, et al. J Head Trauma Rehabil. 2020 Sep/Oct;35(5):324-331. doi: 10.1097/HTR.0000000000000606. J Head Trauma Rehabil. 2020. PMID: 32881766 Free PMC article. - Testing a Multivariate Proteomic Panel for Traumatic Brain Injury Biomarker Discovery: A TRACK-TBI Pilot Study.
Huie JR, Diaz-Arrastia R, Yue JK, Sorani MD, Puccio AM, Okonkwo DO, Manley GT, Ferguson AR; TRACK-TBI Investigators. Huie JR, et al. J Neurotrauma. 2019 Jan 1;36(1):100-110. doi: 10.1089/neu.2017.5449. Epub 2018 Sep 27. J Neurotrauma. 2019. PMID: 30084741 Free PMC article. - Anti-SARS-CoV-2 S-RBD IgG Antibody Responses after COVID-19 mRNA Vaccine in the Chronic Disorder of Consciousness: A Pilot Study.
Pugliese ME, Battaglia R, Cerasa A, Raso MG, Coschignano F, Pagliuso A, Bruschetta R, Pugliese G, Scola P, Tonin P. Pugliese ME, et al. J Clin Med. 2021 Dec 13;10(24):5830. doi: 10.3390/jcm10245830. J Clin Med. 2021. PMID: 34945125 Free PMC article. - Directed evolution of a three-finger neurotoxin by using cDNA display yields antagonists as well as agonists of interleukin-6 receptor signaling.
Naimuddin M, Kobayashi S, Tsutsui C, Machida M, Nemoto N, Sakai T, Kubo T. Naimuddin M, et al. Mol Brain. 2011 Jan 7;4:2. doi: 10.1186/1756-6606-4-2. Mol Brain. 2011. PMID: 21214917 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical